Treatment Strategies in Mild to Moderate COPD

Slides:

Advertisements

Similar presentations

COPD Management of Stable COPD Shyam Rao May 2014.

Advertisements

GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.

Exacerbations. Exacerbations An exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond.

LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,

GOLD 2017 major revision: Summary of key changes

Case-Based Examination of Treatment Options in Type 2 Diabetes Management.

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE):

Upfront Combination Therapy vs Step-Up Approach for PAH:

COPD Management.

The Patient Experience With Systemic Lupus Erythematosus

COPD Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.

Practical Recommendations for COPD:

Assessing COPD in Primary Care

COPD by the Guidelines.

COPD Management.

The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD

Highlights From the Inaugural COPD7USA Conference: Focus on Treatment Challenges in COPD.

Making Decisions With Your Osteoarthritis Patients

Management of Mild to Moderate Asthma

Pseudomonas Lung Infections in Cystic Fibrosis

Motor Fluctuations in Parkinson Disease: Options and Strategies

Modern Strategies for Basal Insulin Use in T2D

COPD Management.

The Latest Data on Oral Prostacyclin Therapy in PAH

Seasonal Allergic Rhinitis

Stepping Up Asthma Control for Effective Management

Dual Bronchodilation in COPD: From Clinical Trial Evidence to Clinical Practice.

Early Dementia Distinguishing AD From MCI

What Is the Role of Dual LAMA/LABA Bronchodilation in COPD Therapy in Light of New Clinical Data?

Volume 153, Issue 4, Pages (April 2018)

Volume 153, Issue 4, Pages (April 2018)

All About PAH:.

Community Health Pearl:

The Resurgence of Topical Treatments Across a Spectrum of Psoriasis

When Would You Use Single Inhaler Triple Therapy in COPD?

Combination Inhaled Therapy in COPD: The Impact of Recent Data

Cardiovascular Comorbidities A Common Occurrence With COPD

Mild to Moderate Asthma

Therapeutic Strategies in COPD Focus on Patient Characteristics and Drug Delivery.

A Primer on Medication Delivery Systems in COPD Management

Diagnosing Focal Epilepsy: A Clinical Case

Translating the Latest and Greatest Advances in PAH Into Clinical Practice.

When Is Biologic Therapy Appropriate for HS?

Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.

When to Start and What to Use

A Primer on Medication Delivery Systems in COPD Management

PAH and Prostacyclin Pathways in Focus

Understanding and Addressing the Needs of Patients With AD

Long-Acting Agents in Severe COPD

Are We Making Progress in the Management of Huntington Disease?

Personalizing COPD Therapy According to Recent Clinical Trial Evidence

Optimizing Joint Health in Hemophilia

Critical Decision Points in Insomnia

Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators

Diagnosi della BPCO 1.

Management of Chronic Stable COPD

Gestione clinica della BPCO

Schematic overview of the suggested pharmacological management of chronic obstructive pulmonary disease (COPD). Schematic overview of the suggested pharmacological.

Merging the Art and Science of Managing nOH in Clinical Practice

Exploring the Use of Adeno-Associated Virus for Gene Therapy

Practical Recommendations for COPD:

Targeted Care for COPD.

Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification based on symptom and risk evaluation. a) GOLD model of symptom/risk evaluation.

Ask the Psoriasis Expert

Agenda. Diagnosis, Assessment, and Treatment of the COPD Patient in Primary Care.

Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting

Shared Decision Making in MS

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) ABCD scheme for classifying patients with COPD with separate appraisal of air-flow limitation.

Motor Fluctuations in PD

Presentation transcript:

Treatment Strategies in Mild to Moderate COPD

Challenges of Early Detection of COPD

CAPTURE Screening Tool

Closing the Gap Recognizing the Symptoms

Early Treatment of COPD May Reduce Rate of Lung Function Decline

GOLD Revisions Focus on Symptoms and Exacerbation History

Application of Refined ABCD Assessment Tool to a Patient Case

Patient Assessment Using mMRC and CAT

Strategies for Patient Assessment

Using GOLD Recommendations for Treatment Strategy

Appropriate Use of Dual Bronchodilators

When Are Inhaled Corticosteroids Beneficial to Patients With COPD?

Triple Therapies

LAMA/LABA Combined Bronchodilators

Inhalation Delivery Systems

Inhaler Use Assessing Patient Technique

Factors To Consider When Selecting a Device

Concluding Remarks

Concluding Remarks (cont)

Abbreviations